NOT YET RECRUITING
NCT07941986
Association Between Maternal Intrapartum Pethidine Exposure and Respiratory Depression in Late-Preterm Newborns
This study aims to investigate whether exposure to pethidine during labor is associated with breathing difficulties in late-preterm newborns. Late-preterm babies are those born between 34 weeks and 36 weeks plus 6 days of pregnancy. Although they are close to full term, they may still have an increased risk of breathing problems after birth.
The study will be conducted at two hospitals: Zagazig University Hospitals in Egypt and Royale Hayat Hospital in Kuwait. It will include approximately 320 mothers and their newborn babies.
The researchers will prospectively observe two groups of mothers receiving combined spinal-epidural (CSE) analgesia during labor. The first group will include mothers who receive pethidine in addition to CSE analgesia as part of their clinical care. The second group will include mothers who receive CSE analgesia without pethidine. The decision to administer pethidine will remain entirely with the treating medical team and will not be determined by the research study.
The main purpose is to compare the occurrence of clinically significant breathing difficulties in newborns during the first 24 hours after birth. The study will also assess the need for newborn resuscitation, oxygen therapy, respiratory support, admission to the neonatal intensive care unit, feeding difficulties, and other neonatal outcomes. Maternal outcomes will also be evaluated.
The findings may improve understanding of the association between maternal intrapartum pethidine exposure and neonatal health, particularly when pethidine is used as an adjunct during labor to facilitate cervical effacement, ripening, and dilatation alongside combined spinal-epidural analgesia. The results may help clarify the potential neonatal respiratory risks associated with this practice, support evidence-based decisions regarding intrapartum pain management and cervical preparation, and contribute to improving maternal and neonatal safety.
Gender: All
Ages: 1 Minute - 24 Hours
Neonatal Respiratory Depression
Late Preterm Infant
Meperidine
+4